No Data
Earnings Preview: MRVI to Report Financial Results Post-market on May 12
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
Express News | Maravai LifeSciences Q1 Revenue USD 56.6 Million Vs. IBES Estimate USD 44.1 Million
Maravai LifeSciences Holdings, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
RBC Capital Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $7